ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents

被引：116

作者：

Neri, E. ^{[1
]}

Bali, M. A. ^{[2
]}

Ba-Ssalamah, A. ^{[3
]}

Boraschi, P. ^{[1
]}

Brancatelli, G. ^{[4
]}

Caseiro Alves, F. ^{[5
,6
]}

Grazioli, L. ^{[7
]}

Helmberger, T. ^{[8
]}

Lee, J. M. ^{[9
]}

Manfredi, R. ^{[10
]}

Marti-Bonmati, L. ^{[11
]}

Matos, C. ^{[2
]}

Merkle, E. M. ^{[12
]}

De Beeck, B. Op ^{[13
]}

Schima, W. ^{[14
,15
]}

Skehan, S. ^{[16
]}

Vilgrain, V. ^{[17
]}

Zech, C. ^{[18
]}

Bartolozzi, C. ^{[1
]}

机构：

[1] Univ Pisa, Dept Diagnost & Intervent Radiol, Pisa, Italy

[2] Hop Erasme, MRI Clin, Dept Radiol, Brussels, Belgium

[3] Med Univ Vienna, Gen Hosp, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria

[4] Univ Palermo, Dept Radiol, Palermo, Italy

[5] Univ Hosp Coimbra, Dept Med Imaging, Coimbra, Portugal

[6] Univ Hosp Coimbra, Fac Med, Coimbra, Portugal

[7] Spedali Civili Brescia, Dept Radiol, Brescia, Italy

[8] Tech Univ Munich, Acad Teaching Hosp, Klinikum Bogenhausen, Dept Diagnost & Intervent Radiol & Nucl Med, D-80290 Munich, Germany

[9] Seoul Natl Univ, Coll Med, Dept Radiol, Div Abdominal Imaging, Seoul, South Korea

[10] Univ Verona, Dept Radiol, I-37100 Verona, Italy

[11] Hosp Univ & Politecn Le Fe, Area Clin Imagen Med, Valencia, Spain

[12] Univ Spital Basel, Klin Radiol & Nukl Med, Basel, Switzerland

[13] Univ Antwerp Hosp, Dept Radiol, Edegem, Belgium

[14] Krankenhaus Barmherzigen Schwestern, KH Goettlicher Heiland, Dept Diagnost & Intervent Radiol, Vienna, Austria

[15] Sankt Josef Krankenhaus, Vienna, Austria

[16] St Vincents Univ Hosp, Dept Radiol, Elm Pk, Dublin 4, Ireland

[17] Hop Beaujon, APHP, Dept Radiol, Clichy, France

[18] Univ Spital Basel, Klin Radiol & Nukl Med, Intervent Radiol, Basel, Switzerland

来源：

EUROPEAN RADIOLOGY | 2016年 / 26卷 / 04期

关键词：

Liver; Biliary tract; Magnetic resonance imaging; Contrast media; Delphi technique; GD-EOB-DTPA; FOCAL NODULAR HYPERPLASIA; ACID-ENHANCED MRI; GADOXETIC ACID; HEPATOCELLULAR-CARCINOMA; MAGNETIC-RESONANCE; GADOBENATE DIMEGLUMINE; HEPATOBILIARY PHASE; 3.0; T; DIAGNOSIS;

D O I：

10.1007/s00330-015-3900-3

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Objectives To develop a consensus and provide updated recommendations on liver MR imaging and the clinical use of liver-specific contrast agents. Methods The European Society of Gastrointestinal and Abdominal Radiology (ESGAR) formed a multinational European panel of experts, selected on the basis of a literature review and their leadership in the field of liver MR imaging. A modified Delphi process was adopted to draft a list of statements. Descriptive and Cronbach's statistics were used to rate levels of agreement and internal reliability of the consensus. Results Three Delphi rounds were conducted and 76 statements composed on MR technique (n = 17), clinical application of liver-specific contrast agents in benign, focal liver lesions (n = 7), malignant liver lesions in non-cirrhotic (n = 9) and in cirrhotic patients (n = 18), diffuse and vascular liver diseases (n = 12), and bile ducts (n = 13). The overall mean score of agreement was 4.84 (SD +/- 0.17). Full consensus was reached in 22 % of all statements in all working groups, with no full consensus reached on diffuse and vascular diseases. Conclusions The consensus provided updated recommendations on the methodology, and clinical indications, of MRI with liver specific contrast agents in the study of liver diseases.

引用

页码：921 / 931

页数：11

共 50 条

[1] ESGAR consensus statement on liver MR imaging and clinical use of liver-specific contrast agents
E. Neri
M. A. Bali
A. Ba-Ssalamah
P. Boraschi
G. Brancatelli
F. Caseiro Alves
L. Grazioli
T. Helmberger
J. M. Lee
R. Manfredi
L. Martì-Bonmatì
C. Matos
E. M. Merkle
B. Op De Beeck
W. Schima
S. Skehan
V. Vilgrain
C. Zech
C. Bartolozzi
European Radiology, 2016, 26 : 921 - 931
[2] Liver-specific MR imaging contrast agents
Hahn, PF
Saini, S
RADIOLOGIC CLINICS OF NORTH AMERICA, 1998, 36 (02) : 287 - +
[3] Liver-specific contrast agents
Koh, Dow-Mu
CANCER IMAGING, 2012, 12 (02): : 363 - 364
[4] Atypical focal nodular hyperplasia of the liver: Imaging features of nonspecific and liver-specific MR contrast agents
Ba-Ssalamah, A
Schima, W
Schmook, MT
Linnau, KF
Schibany, N
Helbich, T
Reimer, P
Laengle, F
Wrba, F
Kurtaran, A
Rayn, M
Mann, FA
AMERICAN JOURNAL OF ROENTGENOLOGY, 2002, 179 (06) : 1447 - 1456
[5] Liver-specific MR imaging contrast agents (vol 35, pg 287, 1998)
Hahn, P
Saini, S
RADIOLOGIC CLINICS OF NORTH AMERICA, 1999, 37 (04) : X - X
[6] LIVER-SPECIFIC CONTRAST AGENTS FOR MRI
STARK, DD
ELIZONDO, G
FRETZ, CJ
INVESTIGATIVE RADIOLOGY, 1990, 25 : S58 - S58
[7] The Clinical Utility of Liver-Specific Ultrasound Contrast Agents During Hepatocellular Carcinoma Imaging
Hawley, Joshua
Tang, Yongqing
Sjostrom, Anders
Fuentes-Alburo, Adolfo
Transquart, Francois
ULTRASOUND IN MEDICINE AND BIOLOGY, 2025, 51 (03): : 415 - 427
[8] Contrast agents for MR imaging of the liver: a clinical overview
A.-E. Mahfouz
B. Hamm
M. Taupitz
European Radiology, 1997, 7 : 507 - 513
[9] Contrast agents for MR imaging of the liver: A clinical overview
Mahfouz, AE
Hamm, B
Taupitz, M
EUROPEAN RADIOLOGY, 1997, 7 (04) : 507 - 513
[10] MRI of the liver.: Clinical significance of nonspecific and liver-specific MRI contrast agents
Ba-Ssalamah, A
Happel, B
Kettenbach, J
Dirisamer, A
Wrba, F
Längle, F
Schima, W
RADIOLOGE, 2004, 44 (12): : 1170 - 1184

← 1 2 3 4 5 →